Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)

White N.J.Watson J.A.Simpson J.A.Mahidol University2023-06-182023-06-182022-07-15Clinical Infectious Diseases Vol.75 No.2 (2022) , 35810584838https://repository.li.mahidol.ac.th/handle/20.500.14594/85716MedicineSevere Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)LetterSCOPUS10.1093/cid/ciac0242-s2.0-851371246191537659135023549